Remiazolam Combined With Esketamine in Painless Bidirectional Endoscopy in Children
Status:
Not yet recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
To observe the sedative effect and safety of remiazolam combined with small dose of
esketamine in painless bidirectional endoscopy in children, and to provide a more reasonable
and safe sedative and analgesic regimen for children's gastrointestinal endoscopy.